Heritage and Specialization As a family-owned CRO with a long-standing focus on dermatology since 1944, TKL Research has established deep expertise and industry credibility in this niche, making it a strategic partner for clients seeking specialized dermatological trial services.

Recent Asset Sale Having sold its clinical trials division to QuintilesIMS in 2016, TKL Research may be positioned to leverage its legacy and ongoing relationships, potentially branching into new service areas or collaborating on integrated clinical trial solutions.

Growth Potential Operating with a revenue range of 25 to 50 million dollars and a mid-sized employee base, TKL Research presents opportunities for scalable partnerships, especially with sponsors looking for customizable, agile research services in dermatology.

Technological Savvy Utilizing a modern tech stack including Salesforce Marketing Cloud and SEO tools, TKL Research demonstrates a commitment to digital engagement and data-driven decision-making, which can enhance partner collaborations and client communication strategies.

Market Positioning Positioned alongside mid-tier CROs like Novella Clinical and Veristat, TKL Research’s expertise and niche specialization present a compelling opportunity for targeted sales efforts focused on dermatology-focused clinical development solutions.